A new report by WHO has laid bare the worrying extent to which the COVID-19 pandemic has disrupted efforts to combat tuberculosis. At the centre of the 2022 Global Tuberculosis Report are the statistics on case notifications. In 2019, the year before the COVID-19 pandemic was declared, 7·1 million new cases of tuberculosis were reported worldwide. In 2020, this number dropped to 5·8 million, before recovering somewhat to 6·4 million in 2021. WHO is confident that the reduced number of reported cases of tuberculosis does not represent a genuine drop in the disease burden. The most likely explanation is, instead, that the first 2 years of the pandemic saw dramatically reduced access to health care and diagnostic services.

With newer TB drugs to go off patent in 2023, MSF calls on Johnson & Johnson, Otsuka, and TB Alliance to remove additional barriers blocking generic manufacturers from entering the market.

RESIST-TB released its October 2022 newsletter with the latest research publications on drug-resistant TB.

Researchers from the University of Oxford have reported findings from a study that investigated whether previously identified correlates of protection associated with risk of full-blown tuberculosis (TB) disease could also be associated with risk of infection from the bacteria that causes TB - highlighting certain correlates in the process.

Several key global health actors have already set plans into motion to answer the 1/4/6x24 Campaign call to action, making major commitments. Two countries have also stepped up as global leaders.

Coinfection of tuberculosis (TB) among people with HIV initiating antiretroviral therapy (ART) aggravates the risk of death, a recent study has found.

A team of researchers say they’ve made a breakthrough that could speed up the search for more effective treatments and vaccines for the world’s No. 1 infectious killer.

TBpeople Ukraine and Club des Amis Damien from the Democratic Republic of Congo were announced as the joint winners of the Stop TB Partnership Community Award 2022. The award ceremony was organized on the sidelines of the Stop TB Partnership Community Summit held in Bangkok, Thailand on 31 October - 4 November 2022.

03 November 2022: In two weeks, the board of the Global Fund to Fight AIDS, Tuberculosis and Malaria will be meeting to decide how much total grant funding will be made available to countries in the next three years. But that funding looks unlikely to include additional pledges from big donors such as the United Kingdom.

New research sheds light on how a genetic mutation affecting mitochondria influences chronic inflammatory disorders and immune responses.